Lilly to build $6.5B Houston factory for its first obesity pill

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Dive Brief: Eli Lilly said it will build a $6.5 billion factory in Houston focused on manufacturing the company’s first obesity pill and other small molecule medicines. The 236-acre site will produce active pharmaceutical ingredients, among them orforglipron, a small, oral GLP-1 receptor agonist, according to a news release. The molecule agonist is up f ...